We present a case where nitroglycerin tablets dissolved in saline and intravenous nitroglycerin solution were nebulized as surrogates for inhaled nitric oxide (iNO) after our iNO supply was depleted during the coronavirus disease 2019 (COVID-19) surge in New York. We gave this treatment to a COVID-19 patient with severe acute respiratory distress syndrome (ARDS) and hypercarbia. In response, the patient had immediate and clinically meaningful improvement in multiple organ systems despite no other interventions or ventilator changes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908862 | PMC |
| http://dx.doi.org/10.1213/XAA.0000000000001376 | DOI Listing |
Publication Analysis
Top Keywords
coronavirus disease
8
acute respiratory
8
respiratory distress
8
distress syndrome
8
nebulized nitroglycerin
4
nitroglycerin coronavirus
4
disease 2019-associated
4
2019-associated acute
4
syndrome case
4
case report
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!